Who owns INMED PHARMACEUTICALS INC?
- Ticker: INM
- CUSIP Number: 457637700
Tip: Access positions for across all investors
Analyze quarterly positions in Inmed Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Inmed Pharmaceuticals stock
Who bought or sold INMED PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sabby Management | 220k | $482k | 100% | Sep 2025 |
|
| DRW Holdings | 36k | $79k | 100% | Sep 2025 |
|
| Virtu Financial | 20k | $45k | 100% | Sep 2025 |
|
| Renaissance Technologies | 17k | $37k | 100% | Sep 2025 |
|
| Thompson Davis & Co | 10k | $22k | 100% | Sep 2025 |
|
| SBI Securities | 300.00 | $657.000000 | 0% | Sep 2025 |
|
| Banque Cantonale Vaudoise | 6.00 | $0 | 0% | Sep 2025 |
|
| Federation des caisses Desjardins du Quebec | 2.00 | $4.000000 | 100% | Sep 2025 |
|
| AllSquare Wealth Management | 1.00 | $3.000000 | 0% | Jun 2025 |
|
Who sold out of Inmed Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Jun 2025 | 7.8k | $25k |
| Tower Research Capital | Jun 2025 | 400.00 | $1.3k |
| Bessemer | Jun 2025 | 1.00 | $0 |